Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00342706 · ClinicalTrials.gov registry record · Phase 2

Building Healthy Teen Relationships and Reproductive Practices to Increase Intervals Between Pregnancies

A Phase 2 study of Teen Pregnancy, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).

Completed
Registry status
Phase 2
Development phase
750
Enrollment target
1
Study location

NCT00342706: Completed Phase 2 study of Teen Pregnancy, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).

NCT00342706 is a Phase 2 study of Teen Pregnancy that has completed, run by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD). The registered enrollment target is 750 participants, below the 1,452-participant average among 3 other Teen Pregnancy trials with a reported enrollment target (48% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00342706, a Phase 2 study of Teen Pregnancy, has completed, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).

COMPLETED
Registry status
Phase 2
Development phase
750 participants
Enrollment target
1
Study location

Study Summary

This study will determine the best ways to help teen mothers stay healthy and to increase the time between their pregnancies to at least 2 years. It is designed to encourage attitudes and behaviors that are generally thought to be related to longer intervals between pregnancies. Children of teen mothers generally receive less health care, have lower IQ scores and are more likely to enter foster care. They have less supportive home environments and higher rates of incarceration and teen childbearing. African-American and Latino teenagers living in the Washington, D.C., metropolitan area who are pregnant with their first baby may be eligible for this study. Mothers or mother figures of the teens also are encouraged to participate. Candidates must be between 15 and 18 year of age and speak English. Teen mothers enrolled in the study take a urine pregnancy test every 6 months during this 2-year study. They are randomly assigned to one of the following two groups: Usual Care Group: Teens in this group are interviewed by telephone for about 1 hour every 6 months and for about 15 minutes at 3, 9, 15 and 21 months. The hour-long interview includes questions about the teen's feelings and behaviors, risks to her health and well being, and how she communicates with her boyfriend and family members. She is also asked about what she does to reach personal goals, what she thinks about sexual health, and what support she gets from her family, boyfriend, or others. The 15-minute interview is an update to check on the teen's health and pregnancy status and to verify contact information. Intervention Group: Teens in this group are asked the same questions as those in the usual care group; however, they are involved in a project designed to encourage them to set goals of furthering their education and training and wait at least 2 years before becoming pregnant again. Teens in this group are counseled on learning to communicate and work out problems with their family and boyfriend

Conditions Studied

Interventions

  • PROCEDURE Community based intervention

Study Locations (1)

Maryland

  • National Institute of Child Health and Human Development (NICHD), 9000 Rockville - Bethesda

Trial Details

FieldValue
Enrollment Target 750 participants
Start Date 2005-01-10
Est. Completion 2011-04-29
Phase Phase 2

What the finished NCT00342706 record still lists

NCT00342706 is an interventional study that assigns participants to a tested intervention. The registered 750 participants enrollment target is mid-sized for trials with a published cap, below the 1,452-participant average among 3 other Teen Pregnancy trials with a reported enrollment target (48% lower).

The record links to 1 condition, with Teen Pregnancy appearing as the primary indexed condition, and to 1 intervention - of which Community based intervention is the first listed.

NCT00342706 reports a single indexed study location in Maryland.

Frequently Asked Questions

What is clinical trial NCT00342706 about?

NCT00342706 is a clinical study titled "Building Healthy Teen Relationships and Reproductive Practices to Increase Intervals Between Pregnancies". This study will determine the best ways to help teen mothers stay healthy and to increase the time between their pregnancies to at least 2 years. It is designed to encourage attitudes and behaviors that are generally thought to be related to longer intervals between pregnancies. Children of teen mot...

What is the current status of trial NCT00342706?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 750 participants. The study started on 2005-01-10. Estimated completion is 2011-04-29.

What conditions does trial NCT00342706 study?

This clinical trial studies the following conditions: Teen Pregnancy.

What interventions are being tested in trial NCT00342706?

The interventions under investigation include: Community based intervention (PROCEDURE).

Who is sponsoring clinical trial NCT00342706?

This trial is sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), which has 305 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00342706 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Teen Pregnancy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02048332 · 750 participants · Phase 1

    Donor-Derived Viral Specific T-cells (VSTs)

  • NCT02087852 · 750 participants

    Kidney Cancer DNA Registry

  • NCT02532452 · 750 participants · Phase 2

    Third Party Viral Specific T-cells (VSTs)

  • NCT03126916 · 750 participants · Phase 3

    Testing the Addition of 131I-MIBG or Lorlatinib to Intensive Therapy in People With High-Risk Neuroblastoma (NBL)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT00342706, the US trial registry maintained by the National Library of Medicine. NCT00342706 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.